Home » Topics » Regulatory

Regulatory
RSS

Levaquin tablets/injection approved for new indication in U.S.

Sep. 22, 2000

Once-daily tramadol enters phase III

Sep. 21, 2000

FDA approves QVAR Inhalation Aerosol for treatment of asthma

Sep. 20, 2000

New formulation of Zyprexa introduced for psychotic disorders and manic episodes

Sep. 20, 2000

Glaxo Wellcome seeks new indication for Relenza

Sep. 19, 2000

New HIV treatment option approved by FDA

Sep. 19, 2000

New therapy for AIDS wasting receives orphan product designation from E.C.

Sep. 15, 2000

Nebulized heparin reduces airways inflammation, improves spirometric parameters in asthma

Sep. 14, 2000

Priority review granted to Femara as first-line breast cancer therapy

Sep. 13, 2000

AstraZeneca commences phase III trial of Seroquel for treatment of bipolar disorder

Sep. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...